Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A phenotypic screening platform for chronic pain therapeutics using all-optical electrophysiology

ABSTRACT: A phenotypic screening platform for chronic pain therapeutics using all-optical electrophysiology

PROVIDER: PRJNA996627 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25342304_1.fastq.gz	Fastqsanger.gz
	SRR25342304_2.fastq.gz	Fastqsanger.gz
	SRR25342305_1.fastq.gz	Fastqsanger.gz
	SRR25342305_2.fastq.gz	Fastqsanger.gz
	SRR25342306_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

A phenotypic screening platform for chronic pain therapeutics using all-optical electrophysiology

Project description:Chronic pain associated with osteoarthritis (OA) remains an intractable problem with few effective treatment options. New approaches are needed to model the disease biology and to drive discovery of therapeutics. Here, we present an in vitro model of OA pain, where dorsal root ganglion (DRG) sensory neurons were sensitized by a defined mixture of disease-relevant inflammatory mediators, here called Sensitizing PAin Reagent Composition or SPARC. OA-SPARC components showed synergistic or additive effects when applied in combination and induced pain phenotypes in vivo. To measure the effect of OA-SPARC on neural firing in a scalable format for drug discovery, we used a custom system for high throughput all-optical electrophysiology. This system enabled light-based membrane voltage recordings from hundreds of neurons in parallel with single cell resolution and a throughput of up to 500,000 neurons per day, with patch clamp-like single action potential resolution. A computational framework was developed to construct a multiparameter OA-SPARC neuronal phenotype and to quantitatively assess phenotype reversal by candidate pharmacology with different mechanisms of action. We screened ~3000 approved drugs and mechanistically focused compounds, yielding data from over 1.2 million individual neurons with detailed assessment of both functional OA-SPARC phenotype rescue and orthogonal “off-target” effects. Analysis of confirmed hits revealed diverse potential analgesic mechanisms including well-known ion channel modulators as well as less characterized mechanisms including MEK inhibitors and tyrosine kinase modulators, providing validation of the platform for pain drug discovery.

2023-08-02 | GSE237797 | GEO

A Transcriptomics-Based Computational Drug Repositioning Pipeline Identifies Simvastatin And Primaquine As Novel Therapeutics For Endometriosis Pain

Project description:Endometriosis is a disease with limited medical treatment options and a strong need for new therapeutic strategies. We previously applied a transcriptomics-based computational drug repositioning pipeline to publicly available bulk transcriptomic data to identify potential therapeutics for endometriosis. The drug candidates identified in silico includes fenoprofen, primaquine, and simvastatin. Validation of these drugs in our rat endometrial model determined that they significantly reduced endometriosis-associated vaginal hyperalgesia, a surrogate marker for endometriosis-related pain. The signatures of DEGs from uteri and lesions demonstrated reversal of the endometriosis disease signature with simvastatin and primaquine treatment.

2025-06-25 | GSE296883 | GEO

Linked optical and gene expression profiling of single cells at high throughput

Project description:Single cell RNA sequencing has emerged as a powerful tool for characterizing cells, but not all phenotypes of interest can be observed through gene expression alone. Linking sequencing with optical analysis has provided insight into the molecular basis behind cellular function, but current approaches have limited throughput. Here, we present a high throughput platform for linked optical and gene expression profiling of single cells. We demonstrate accurate fluorescence and gene expression measurements from thousands of cells in a single experiment and use the platform to characterize DNA and RNA changes in Jurkat cells through the cell-cycle. In addition to its scalability, our integration of microfluidics and array-based molecular biology holds promise for comprehensive multi-omics profiling of single cells.

2019-09-05 | GSE136871 | GEO

A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity

Project description:A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity

| PRJNA768277 | ENA

Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics

Project description:Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics

| PRJNA595156 | ENA

A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity [scRNAseq]

Project description:A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity [scRNAseq]

| PRJNA764673 | ENA

Micropillar-based phenotypic screening platform uncovers involvement of HDAC2 in nuclear deformability

Project description:Micropillar-based phenotypic screening platform uncovers involvement of HDAC2 in nuclear deformability